Earnings Report: Ferozsons Laboratories (PSX: FEROZ) today reported Financial Results for the Twelve months ended June 30, 2017

Unconsolidated Profit and Loss Account - For the Twelve Months Ended

Key Financials

2017

2016

% Change

Amounts in PKR

Net Revenue

4,311,441,718

10,186,496,154

-57.67%

Cost of Sales

2,534,669,504

6,077,657,868

-58.30%

Gross Profit

1,776,772,214

4,108,838,286

-56.76%

Admin: Expenses

289,129,914

276,235,535

4.67%

Selling & Dist: Expenses

913,763,385

1,033,035,251

-11.55%

Other Expenses

3,216,963

260,905,050

-98.77%

Other income

47,849,556

126,515,313

-62.18%

Profit from Operations

618,511,508

2,665,177,763

-76.79%

Finance Costs

16,293,573

11,152,570

46.10%

Profit before Taxation

602,217,935

2,654,025,193

-77.31%

Taxation

208,553,225

549,538,096

-62.05%

Profit after Taxation

393,664,710

2,104,487,097

-81.29%

EPS - Basic & diluted

13.04

69.72

-81.30%